Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;30(4):499-505.
doi: 10.1007/s10278-017-9993-2.

Malignancy Detection on Mammography Using Dual Deep Convolutional Neural Networks and Genetically Discovered False Color Input Enhancement

Affiliations

Malignancy Detection on Mammography Using Dual Deep Convolutional Neural Networks and Genetically Discovered False Color Input Enhancement

Philip Teare et al. J Digit Imaging. 2017 Aug.

Abstract

Breast cancer is the most prevalent malignancy in the US and the third highest cause of cancer-related mortality worldwide. Regular mammography screening has been attributed with doubling the rate of early cancer detection over the past three decades, yet estimates of mammographic accuracy in the hands of experienced radiologists remain suboptimal with sensitivity ranging from 62 to 87% and specificity from 75 to 91%. Advances in machine learning (ML) in recent years have demonstrated capabilities of image analysis which often surpass those of human observers. Here we present two novel techniques to address inherent challenges in the application of ML to the domain of mammography. We describe the use of genetic search of image enhancement methods, leading us to the use of a novel form of false color enhancement through contrast limited adaptive histogram equalization (CLAHE), as a method to optimize mammographic feature representation. We also utilize dual deep convolutional neural networks at different scales, for classification of full mammogram images and derivative patches combined with a random forest gating network as a novel architectural solution capable of discerning malignancy with a specificity of 0.91 and a specificity of 0.80. To our knowledge, this represents the first automatic stand-alone mammography malignancy detection algorithm with sensitivity and specificity performance similar to that of expert radiologists.

Keywords: Convolutional neural networks; Deep learning; Machine learning; Mammography.

PubMed Disclaimer

Conflict of interest statement

Philip Teare, Eyal Toledano, and Eldad Elnekave are employees of Zebra Medical Vision.

Oshra Benzaquen has no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
In generational order from left to right, the same image of a red kite is transformed by the current generation of image preprocessing, created by the evolutionary system described. Images courtesy of PT and Prof. Abigail Morrison
Scheme 1
Scheme 1
Comparing accuracy of unenhanced and enhanced input training. Accuracy score against training time for region of interest binary classification of malignancy risk (p < 0.005)
Fig. 2
Fig. 2
Enhanced inputs: normal window patch (a), window patch containing malignancy (b), normal full image (c), and full image containing malignancy and scarring (d). All images shown are from different patients
Fig. 3
Fig. 3
Varying the CLAHE window and clipping parameters differently across the color channels affords useful enhancement across a wider range of fidelity resolutions, across the majority of the breast. Affording sharper structural enhancement over more scales of resolution and windows of tonal range
Fig. 4
Fig. 4
Illustration showing the dimensions of the sliding window region, traversed across the full image, used to generate the map of regions of interest, and eventually their local probability of risk
Fig. 5
Fig. 5
System architecture demonstrating full mammogram and patch input into dual deep CNN instances with an additional final random forest analytic component
Scheme 2
Scheme 2
Final classification receiver operator characteristic curve

References

    1. American Cancer Society Cancer Facts & Figures 2015. Cancer Facts Fig. 2015;2015:1–9.
    1. Tabar L, Vitak B, Chen T, Yen A, Cohen A, Tot T, Chiu S, Chen S, Fann J, Rosell J, Fohlin H, Smith R, Duffy S, Al E. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades - with comments. Radiology. 2011;260(3):658–663. doi: 10.1148/radiol.11110469. - DOI - PubMed
    1. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K. Breast-cancer screening--viewpoint of the IARC Working Group. N. Engl. J. Med. 2015;372(24):2353–2358. doi: 10.1056/NEJMsr1504363. - DOI - PubMed
    1. Kavanagh AM, Giles GG, Mitchell H, Cawson JN. The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status. J. Med. Screen. 2000;7(2):105–110. doi: 10.1136/jms.7.2.105. - DOI - PubMed
    1. Lehman CD, Wellman RD, Buist DSM, Kerlikowske K, Tosteson ANA, Miglioretti DL, Breast Cancer Surveillance Consortium Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. JAMA Intern. Med. 2015;175(11):1828–1837. doi: 10.1001/jamainternmed.2015.5231. - DOI - PMC - PubMed